176 related articles for article (PubMed ID: 35740344)
41. Rs12039395 Variant Influences the Expression of hsa-miR-181a-5p and PTEN Toward Colorectal Cancer Risk.
El-Korany WA; Zahran WE; Alm El-Din MA; Al-Shenawy HA; Soliman AF
Dig Dis Sci; 2024 Jun; ():. PubMed ID: 38940971
[TBL] [Abstract][Full Text] [Related]
42. Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer.
Wang M; Gu H; Wang S; Qian H; Zhu W; Zhang L; Zhao C; Tao Y; Xu W
Mol Med Rep; 2012 Jun; 5(6):1514-20. PubMed ID: 22406928
[TBL] [Abstract][Full Text] [Related]
43. [Prediction of regulating network of innate immune signaling molecule hsa-miR-181a in stroke development based on bioinformatics analysis].
Lyu Y; Qian Y; Fu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Aug; 31(8):1042-7. PubMed ID: 26271976
[TBL] [Abstract][Full Text] [Related]
44. Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer.
Liu L; Wu SQ; Zhu X; Xu R; Ai K; Zhang L; Zhao XK
Neoplasma; 2019 Sep; 66(5):736-745. PubMed ID: 31169020
[TBL] [Abstract][Full Text] [Related]
45. Hsa-miR-584-5p as a novel candidate biomarker in Turkish men with severe coronary artery disease.
Coban N; Pirim D; Erkan AF; Dogan B; Ekici B
Mol Biol Rep; 2020 Feb; 47(2):1361-1369. PubMed ID: 31863331
[TBL] [Abstract][Full Text] [Related]
46. Glycolysis-Related LINC02432/Hsa-miR-98-5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma.
Tan P; Li M; Liu Z; Li T; Zhao L; Fu W
Front Pharmacol; 2022; 13():937413. PubMed ID: 35795552
[TBL] [Abstract][Full Text] [Related]
47. Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey.
Lin Y; Miao Z; Zhang X; Wei X; Hou J; Huang Y; Shen B
Front Genet; 2020; 11():596826. PubMed ID: 33519899
[No Abstract] [Full Text] [Related]
48. LINC01018 and SMIM25 sponged miR-182-5p in endometriosis revealed by the ceRNA network construction.
Jiang L; Zhang M; Wang S; Xiao Y; Wu J; Zhou Y; Fang X
Int J Immunopathol Pharmacol; 2020; 34():2058738420976309. PubMed ID: 33237828
[TBL] [Abstract][Full Text] [Related]
49. A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.
Wang WJ; Li HT; Yu JP; Han XP; Xu ZP; Li YM; Jiao ZY; Liu HB
J Surg Res; 2019 Mar; 235():22-33. PubMed ID: 30691798
[TBL] [Abstract][Full Text] [Related]
50. Role of extracellular LncRNA-SNHG14/miRNA-3940-5p/NAP12 mRNA in colorectal cancer.
Matboli M; Shafei AE; Ali MA; El-Din Ahmed TS; Naser M; Abdel-Rahman T; Anber N; Ali M
Arch Physiol Biochem; 2021 Dec; 127(6):479-485. PubMed ID: 31397210
[TBL] [Abstract][Full Text] [Related]
51. Integrated analysis of transcriptome profiling of lncRNAs and mRNAs in livers of type 2 diabetes mellitus.
Lan X; Han J; Wang B; Sun M
Physiol Genomics; 2022 Feb; 54(2):86-97. PubMed ID: 35073196
[TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
[TBL] [Abstract][Full Text] [Related]
53. LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.
Lv Y; Lv X; Yang H; Qi X; Wang X; Li C; Shang X; Guo H; Zhang J; Zhang Y
Front Oncol; 2021; 11():678474. PubMed ID: 34026654
[TBL] [Abstract][Full Text] [Related]
54. The LINC01929/miR-6875-5p/ADAMTS12 Axis in the ceRNA Network Regulates the Development of Advanced Bladder Cancer.
Xiong Y; Pang M; Du Y; Yu X; Yuan J; Liu W; Wang L; Liu X
Front Oncol; 2022; 12():856560. PubMed ID: 35646642
[TBL] [Abstract][Full Text] [Related]
55. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
56. Comprehensive Analysis of miRNA-Mediated Regulatory Network and Identification of Prognosis Biomarkers in Rectal Cancer.
Tang T; Yu S; Song Z; Pan X; Xu F; Wu Y; Zhang L
Front Genet; 2022; 13():792984. PubMed ID: 35495167
[TBL] [Abstract][Full Text] [Related]
57. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
58. Screening for Regulatory Network of miRNA-Inflammation, Oxidative Stress and Prognosis-Related mRNA in Acute Myocardial Infarction: An in silico and Validation Study.
Yin X; Wang X; Wang S; Xia Y; Chen H; Yin L; Hu K
Int J Gen Med; 2022; 15():1715-1731. PubMed ID: 35210840
[TBL] [Abstract][Full Text] [Related]
59. Overexpressing lncRNA
Xu F; Zha G; Wu Y; Cai W; Ao J
Onco Targets Ther; 2018; 11():8855-8863. PubMed ID: 30573973
[TBL] [Abstract][Full Text] [Related]
60. [Construction and analysis of competitive endogenous RNA regulatory network related to gastric cancer].
Li R; Jiang WJ; Jin SL; Zhao RH; Cao XG; Zong H
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):115-121. PubMed ID: 32135645
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
